ResearcherSeoul National UniversityActive in the last 2 years
Ho‐Seong Han
Matched on ORCID iD 0000-0001-9659-1260; OpenAlex author ID A5000750700. Sources: OpenAlex.
Their work
- Papers
- 33 (first author 4, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 72
2012: 2 papers · 2013: none · 2014: none · 2015: 4 papers · 2016: 1 paper · 2017: 4 papers · 2018: 1 paper · 2019: 2 papers · 2020: 2 papers · 2021: 6 papers · 2022: 2 papers · 2023: 2 papers · 2024: 3 papers · 2025: 4 papers
Papers 33
- "Obesity Paradox" as a new insight from long-term survivors in pancreatic cancer patients. First author DOI 10.1016/j.hpb.2025.03.450↗
- Spatial transcriptomics reveal high T cell and monocyte status as predictive and prognostic markers in pancreatic cancer. Co-author DOI 10.1186/s12967-025-06599-9↗
- Role of diabetes-related inflammation in pancreatic cancer evaluated by aptamer-based detection of circulating tumor cells in a streptozotocin-induced Panc02-t… Co-author DOI 10.14701/ahbps.25-120↗
- Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, and Oral Immunosuppression. Co-author DOI 10.3390/medicina61040586↗
- Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens to predict post-surgical recurrence: A prospective cohort study. Co-author DOI 10.1016/j.pan.2024.03.013↗
- Feasibility of Early Diagnosis of Pancreatic Cancer using reagent for analyzing purine metabolite (Hypoxanthine, Xanthine) in urine Co-author DOI 10.21203/rs.3.rs-5011761/v1↗
- Analysis of Recent Improvement of Survival Outcomes in Patients with Pancreatic Cancer Who Underwent Upfront Surgery. Co-author DOI 10.5009/gnl230303↗
- Validation of the Anatomical and Biological Definitions of Borderline Resectable Pancreatic Cancer According to the 2017 International Consensus for Survival a… Last author DOI 10.1245/s10434-022-13043-5↗
- Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives. First author DOI 10.4251/wjgo.v15.i6.911↗
- Comparison of oncologic outcomes between open and laparoscopic distal pancreatectomy for pancreatic ductal adenocarcinoma using data from the KOTUS-BP national… Co-author DOI 10.1016/j.hpb.2022.01.012↗
- Four-Tier Pathologic Tumor Regression Grading System Predicts the Clinical Outcome in Patients Who Undergo Surgical Resection for Locally Advanced Pancreatic C… Co-author DOI 10.5009/gnl20312↗
- Usefulness of artificial intelligence for predicting recurrence following surgery for pancreatic cancer: Retrospective cohort study. Co-author DOI 10.1016/j.ijsu.2021.106050↗
- Tailored adjuvant gemcitabine versus 5-fluorouracil/folinic acid based on hENT1 immunohistochemical staining in resected pancreatic ductal adenocarcinoma: A bi… Co-author DOI 10.1016/j.pan.2021.02.022↗
- Surgical Resection or Ablation for Recurrent Pancreatic Ductal Adenocarcinoma: An Analysis of Oncologic Outcomes According to the Recurrence Type. First author DOI 10.1097/as9.0000000000000096↗
- Impact of Acute Inflammation on the Survival Outcomes of Patients with Resected Pancreatic Ductal Adenocarcinoma. First author DOI 10.1159/000520063↗
- Clinical Impact of Unexpected Para-Aortic Lymph Node Metastasis in Surgery for Resectable Pancreatic Cancer. Co-author DOI 10.3390/cancers13174454↗
- Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Resul… Co-author DOI 10.5009/gnl20306↗
- Prognosis prediction of pancreatic cancer after curative intent surgery using imaging parameters derived from F-18 fluorodeoxyglucose positron emission tomogra… Co-author DOI 10.1097/md.0000000000021829↗
- Human equilibrative nucleoside transporter-1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression; do they have survival impact to panc… Co-author DOI 10.14701/ahbps.2020.24.2.127↗
- Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejso.2019.06.002↗
- Laparoscopic subtotal pancreatectomy with radical antegrade modular pancreatosplenectomy for left-sided pancreatic cancer. Co-author DOI 10.1016/j.suronc.2018.12.006↗
- The impact of acute inflammation on progression and metastasis in pancreatic cancer animal model. Co-author DOI 10.1016/j.suronc.2017.11.008↗
- Prognostic Relevance of the Timing of Initiating and the Completion of Adjuvant Therapy in Patients with Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1007/s00268-016-3798-1↗
- Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer. Co-author DOI 10.1016/j.surg.2016.12.038↗
- Prognostic value of p21-activated kinase 4 in resected pancreatic cancer. Last author DOI 10.1111/apm.12705↗
- The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Co-author DOI 10.1177/1010428317718403↗
- Prognostic relevance of preoperative diabetes mellitus and the degree of hyperglycemia on the outcomes of resected pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jso.24133↗
- Lower maximum standardized uptake value of fluorine-18 fluorodeoxyglucose positron emission tomography coupled with computed tomography imaging in pancreatic d… Co-author DOI 10.1016/j.amjsurg.2014.06.038↗
- Postoperative early thromboembolism as a prognostic indicator in patients with curatively resected pancreatic cancer. Co-author DOI 10.1016/j.amjsurg.2014.12.051↗
- Presence of pancreatic intraepithelial neoplasia-3 in a background of chronic pancreatitis in pancreatic cancer patients. Co-author DOI 10.1111/cas.12744↗
- Postoperative carcinoembryonic antigen as a complementary tumor marker of carbohydrate antigen 19-9 in pancreatic ductal adenocarcinoma. Co-author DOI 10.3346/jkms.2015.30.3.259↗
- Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients. Last author DOI 10.1111/j.1440-1827.2011.02772.x↗
- Postoperative prognostic predictors of pancreatic ductal adenocarcinoma: clinical analysis and immunoprofile on tissue microarrays. Co-author DOI 10.1245/s10434-012-2277-7↗
Closest collaborators
The 25 strongest of 72 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoo‐Seok Yoon · 31 shared papers, 2012–2025 · strength 4.37
- Paper Role of diabetes-related inflammation in pancreatic cancer evaluated by aptamer-based detection of circulating tumor ce… DOI 10.14701/ahbps.25-120↗
- Paper "Obesity Paradox" as a new insight from long-term survivors in pancreatic cancer patients. DOI 10.1016/j.hpb.2025.03.450↗
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- Boram Lee · 7 shared papers, 2021–2025 · strength 1.59
- Paper "Obesity Paradox" as a new insight from long-term survivors in pancreatic cancer patients. DOI 10.1016/j.hpb.2025.03.450↗
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- Paper Feasibility of Early Diagnosis of Pancreatic Cancer using reagent for analyzing purine metabolite (Hypoxanthine, Xanthi… DOI 10.21203/rs.3.rs-5011761/v1↗
- Jai Young Cho · 14 shared papers, 2012–2025 · strength 1.46
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- Paper Validation of the Anatomical and Biological Definitions of Borderline Resectable Pancreatic Cancer According to the 201… DOI 10.1245/s10434-022-13043-5↗
- Paper Impact of Acute Inflammation on the Survival Outcomes of Patients with Resected Pancreatic Ductal Adenocarcinoma. DOI 10.1159/000520063↗
- Jun Suh Lee · 7 shared papers, 2021–2025 · strength 1.32
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- Paper Analysis of Recent Improvement of Survival Outcomes in Patients with Pancreatic Cancer Who Underwent Upfront Surgery. DOI 10.5009/gnl230303↗
- Paper Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives. DOI 10.4251/wjgo.v15.i6.911↗
- Jin‐Hyeok Hwang · 14 shared papers, 2012–2025 · strength 1.30
- Paper Spatial transcriptomics reveal high T cell and monocyte status as predictive and prognostic markers in pancreatic cance… DOI 10.1186/s12967-025-06599-9↗
- Paper Analysis of Recent Improvement of Survival Outcomes in Patients with Pancreatic Cancer Who Underwent Upfront Surgery. DOI 10.5009/gnl230303↗
- Paper Four-Tier Pathologic Tumor Regression Grading System Predicts the Clinical Outcome in Patients Who Undergo Surgical Res… DOI 10.5009/gnl20312↗
- Yeshong Park · 5 shared papers, 2023–2025 · strength 1.28
- Paper Role of diabetes-related inflammation in pancreatic cancer evaluated by aptamer-based detection of circulating tumor ce… DOI 10.14701/ahbps.25-120↗
- Paper "Obesity Paradox" as a new insight from long-term survivors in pancreatic cancer patients. DOI 10.1016/j.hpb.2025.03.450↗
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- MeeYoung Kang · 5 shared papers, 2023–2025 · strength 1.21
- Paper "Obesity Paradox" as a new insight from long-term survivors in pancreatic cancer patients. DOI 10.1016/j.hpb.2025.03.450↗
- Paper Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, an… DOI 10.3390/medicina61040586↗
- Paper Feasibility of Early Diagnosis of Pancreatic Cancer using reagent for analyzing purine metabolite (Hypoxanthine, Xanthi… DOI 10.21203/rs.3.rs-5011761/v1↗
- Jaihwan Kim · 10 shared papers, 2015–2025 · strength 1.13
- Paper Spatial transcriptomics reveal high T cell and monocyte status as predictive and prognostic markers in pancreatic cance… DOI 10.1186/s12967-025-06599-9↗
- Paper Analysis of Recent Improvement of Survival Outcomes in Patients with Pancreatic Cancer Who Underwent Upfront Surgery. DOI 10.5009/gnl230303↗
- Paper Four-Tier Pathologic Tumor Regression Grading System Predicts the Clinical Outcome in Patients Who Undergo Surgical Res… DOI 10.5009/gnl20312↗
- Jong-Chan Lee · 6 shared papers, 2017–2024 · strength 0.80
- Paper Analysis of Recent Improvement of Survival Outcomes in Patients with Pancreatic Cancer Who Underwent Upfront Surgery. DOI 10.5009/gnl230303↗
- Paper Four-Tier Pathologic Tumor Regression Grading System Predicts the Clinical Outcome in Patients Who Undergo Surgical Res… DOI 10.5009/gnl20312↗
- Paper Tailored adjuvant gemcitabine versus 5-fluorouracil/folinic acid based on hENT1 immunohistochemical staining in resecte… DOI 10.1016/j.pan.2021.02.022↗
- Haeryoung Kim · 8 shared papers, 2012–2024 · strength 0.76
- Paper Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens to predict post-surgical recurrence: … DOI 10.1016/j.pan.2024.03.013↗
- Paper Four-Tier Pathologic Tumor Regression Grading System Predicts the Clinical Outcome in Patients Who Undergo Surgical Res… DOI 10.5009/gnl20312↗
- Paper Tailored adjuvant gemcitabine versus 5-fluorouracil/folinic acid based on hENT1 immunohistochemical staining in resecte… DOI 10.1016/j.pan.2021.02.022↗
- Kwangrok Jung · 3 shared papers, 2021–2025 · strength 0.55
- Paper Spatial transcriptomics reveal high T cell and monocyte status as predictive and prognostic markers in pancreatic cance… DOI 10.1186/s12967-025-06599-9↗
- Paper Analysis of Recent Improvement of Survival Outcomes in Patients with Pancreatic Cancer Who Underwent Upfront Surgery. DOI 10.5009/gnl230303↗
- Paper Clinical Impact of Unexpected Para-Aortic Lymph Node Metastasis in Surgery for Resectable Pancreatic Cancer. DOI 10.3390/cancers13174454↗
- Jinju Kim · 2 shared papers, 2024–2025 · strength 0.50
- Yeon Bi Han · 2 shared papers, 2024–2025 · strength 0.42
- Paper Spatial transcriptomics reveal high T cell and monocyte status as predictive and prognostic markers in pancreatic cance… DOI 10.1186/s12967-025-06599-9↗
- Paper Microscopic tumor mapping of post-neoadjuvant therapy pancreatic cancer specimens to predict post-surgical recurrence: … DOI 10.1016/j.pan.2024.03.013↗
- Soomin Ahn · 2 shared papers, 2022–2025 · strength 0.39
- Paper Spatial transcriptomics reveal high T cell and monocyte status as predictive and prognostic markers in pancreatic cance… DOI 10.1186/s12967-025-06599-9↗
- Paper Four-Tier Pathologic Tumor Regression Grading System Predicts the Clinical Outcome in Patients Who Undergo Surgical Res… DOI 10.5009/gnl20312↗
- Jin Seok Heo · 3 shared papers, 2021–2022 · strength 0.34
- Paper Usefulness of artificial intelligence for predicting recurrence following surgery for pancreatic cancer: Retrospective … DOI 10.1016/j.ijsu.2021.106050↗
- Paper Comparison of oncologic outcomes between open and laparoscopic distal pancreatectomy for pancreatic ductal adenocarcino… DOI 10.1016/j.hpb.2022.01.012↗
- Paper Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: … DOI 10.5009/gnl20306↗
- Jin‐Young Jang · 3 shared papers, 2021–2022 · strength 0.34
- Paper Usefulness of artificial intelligence for predicting recurrence following surgery for pancreatic cancer: Retrospective … DOI 10.1016/j.ijsu.2021.106050↗
- Paper Comparison of oncologic outcomes between open and laparoscopic distal pancreatectomy for pancreatic ductal adenocarcino… DOI 10.1016/j.hpb.2022.01.012↗
- Paper Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: … DOI 10.5009/gnl20306↗
- Jae Hyup Jung · 2 shared papers, 2021–2024 · strength 0.33
- Dae Wook Hwang · 3 shared papers, 2015–2021 · strength 0.29
- Paper Human equilibrative nucleoside transporter-1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expressi… DOI 10.14701/ahbps.2020.24.2.127↗
- Paper Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: … DOI 10.5009/gnl20306↗
- Paper Lower maximum standardized uptake value of fluorine-18 fluorodeoxyglucose positron emission tomography coupled with com… DOI 10.1016/j.amjsurg.2014.06.038↗
- Jin Won Kim · 2 shared papers, 2017–2024 · strength 0.27
- Jin Peng He · 1 shared paper, 2024 · strength 0.26
- Ho Kyoung Hwang · 2 shared papers, 2021–2022 · strength 0.25
- Paper Usefulness of artificial intelligence for predicting recurrence following surgery for pancreatic cancer: Retrospective … DOI 10.1016/j.ijsu.2021.106050↗
- Paper Comparison of oncologic outcomes between open and laparoscopic distal pancreatectomy for pancreatic ductal adenocarcino… DOI 10.1016/j.hpb.2022.01.012↗
- Chang Moo Kang · 2 shared papers, 2021–2022 · strength 0.25
- Paper Usefulness of artificial intelligence for predicting recurrence following surgery for pancreatic cancer: Retrospective … DOI 10.1016/j.ijsu.2021.106050↗
- Paper Comparison of oncologic outcomes between open and laparoscopic distal pancreatectomy for pancreatic ductal adenocarcino… DOI 10.1016/j.hpb.2022.01.012↗
- Young Hoon Kim · 2 shared papers, 2017–2022 · strength 0.23
- Dong Woo Shin · 2 shared papers, 2019–2021 · strength 0.23
- Paper Tailored adjuvant gemcitabine versus 5-fluorouracil/folinic acid based on hENT1 immunohistochemical staining in resecte… DOI 10.1016/j.pan.2021.02.022↗
- Paper Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinom… DOI 10.1016/j.ejso.2019.06.002↗
- Joon Seong Park · 2 shared papers, 2021–2022 · strength 0.21
- Paper Comparison of oncologic outcomes between open and laparoscopic distal pancreatectomy for pancreatic ductal adenocarcino… DOI 10.1016/j.hpb.2022.01.012↗
- Paper Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: … DOI 10.5009/gnl20306↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.